HARBIN FUERJIA TECHNOLOGY CO., LTD. Harbin Fuerjia Technology Co., Ltd. Stock
Equities
301371
CNE1000066F0
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.59 CNY | -0.14% |
|
+5.78% | -4.24% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.21B 306M | Sales 2025 * | 2.46B 341M | Capitalization | 14.66B 2.03B |
|---|---|---|---|---|---|
| Net income 2024 * | 846M 117M | Net income 2025 * | 929M 129M | EV / Sales 2024 * | 6.64 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.96 x |
| P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
15.8
x | Employees | - |
| Yield 2024 * |
2.73% | Yield 2025 * |
2.73% | Free-Float | 10.07% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.81% | ||
| 1 week | +5.93% | ||
| Current month | +5.93% | ||
| 1 month | +10.49% | ||
| 3 months | +24.08% | ||
| 6 months | -15.98% | ||
| Current year | -4.11% |
1 week
34.30
38.58
1 month
29.5038.58
Current year
25.2143.75
1 year
25.2180.04
3 years
25.2180.04
5 years
25.2180.04
10 years
25.2180.04
| Managers | Title | Age | Since |
|---|---|---|---|
Li Guo Zhang
CEO | Chief Executive Officer | 60 | 17-11-27 |
Bai Jiao Deng
DFI | Director of Finance/CFO | 41 | 17-12-31 |
Xu Zhang
BRD | Director/Board Member | 30 | 18-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Fu Zhao
BRD | Director/Board Member | 61 | 21-02-28 |
Li Guo Zhang
CEO | Chief Executive Officer | 60 | 17-11-27 |
Hong Bo Zhu
CHM | Chairman | 48 | 19-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 36.59 | -0.14% | 3 424 376 |
| 24-05-09 | 36.64 | -0.81% | 4,647,673 |
| 24-05-08 | 36.94 | -2.22% | 5,151,530 |
| 24-05-07 | 37.78 | +2.86% | 7,617,880 |
| 24-05-06 | 36.73 | +6.19% | 6,176,906 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes
Harbin Fuerjia Technology Development Co Ltd is a China-based company engaged in the research, development, production and sales of professional skin care products. The Company's main products include medical device dressing products and functional skin care products, mainly including dressings, patches, film products, and other forms of products such as water, essence, lotion, spray, and freeze-dried powder. Its products are mainly Class II medical device products suitable for mild to moderate acne, promoting wound healing and skin repair, supplemented by various forms of functional skin care products.
Calendar
2024-05-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
36.59
CNY
Average target price
42.93
CNY
Spread / Average Target
+17.32%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.11% | 2.03B | |
| +9.48% | 27.45B | |
| -28.65% | 3.11B | |
| -15.44% | 2.55B | |
| +18.49% | 2.48B | |
| +11.11% | 2.08B | |
| +5.56% | 1.55B | |
| +1.69% | 1.29B | |
| +29.73% | 1.23B | |
| +8.01% | 1.16B |
- Stock Market
- Equities
- 301371 Stock